Search

everythinglearnresearchcommunity

for

Search:↓

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Ritlecitinib works well and is safe for treating alopecia areata.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

The updated criteria improve the accuracy of diagnosing lupus.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

Enteral supplements can improve symptoms of Cronkhite-Canada syndrome.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Ruxolitinib can cause a delayed skin reaction on the nose.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Upadacitinib may effectively treat resistant lichen planopilaris.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Cetirizine is effective and safe for treating various allergies, with personalized dosing improving its use.

Social media can help compare the effectiveness and safety of new arthritis medications.